Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

INTRODUCTION: The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a two-dose schedule. We assessed whether a third dose of the homologous or a different vaccine could boost immune responses. METHODS: RHH-001 is a phase 4, participant masked, two centre, safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa Clemens, Sue Ann, Weckx, Lily, Clemens, Ralf, Almeida Mendes, Ana Verena, Ramos Souza, Alessandra, Silveira, Mariana B V, da Guarda, Suzete Nascimento Farias, de Nobrega, Maristela Miyamoto, de Moraes Pinto, Maria Isabel, Gonzalez, Isabela G S, Salvador, Natalia, Franco, Marilia Miranda, de Avila Mendonça, Renata Navis, Queiroz Oliveira, Isabelle Silva, de Freitas Souza, Bruno Solano, Fraga, Mayara, Aley, Parvinder, Bibi, Sagida, Cantrell, Liberty, Dejnirattisai, Wanwisa, Liu, Xinxue, Mongkolsapaya, Juthathip, Supasa, Piyada, Screaton, Gavin R, Lambe, Teresa, Voysey, Merryn, Pollard, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782575/
https://www.ncbi.nlm.nih.gov/pubmed/35074136
http://dx.doi.org/10.1016/S0140-6736(22)00094-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782575/
https://www.ncbi.nlm.nih.gov/pubmed/35074136
http://dx.doi.org/10.1016/S0140-6736(22)00094-0

Ejemplares similares